Quantum-Si (NASDAQ:QSI) Director Charles Kummeth Buys 500,000 Shares

Quantum-Si Incorporated (NASDAQ:QSI) Director Charles Kummeth purchased 500,000 shares of the stock in a transaction that occurred on Thursday, March 5th. The shares were bought at an average cost of $0.92 per share, for a total transaction of $460,000.00. Following the acquisition, the director owned 855,000 shares of the company’s stock, valued at approximately $786,600. The trade was a 140.85% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.

Quantum-Si Stock Up 7.4%

QSI opened at $0.93 on Tuesday. Quantum-Si Incorporated has a 52 week low of $0.84 and a 52 week high of $3.10. The business has a 50 day moving average price of $1.09 and a two-hundred day moving average price of $1.37. The company has a market cap of $199.52 million, a PE ratio of -1.78 and a beta of 3.00.

Quantum-Si (NASDAQ:QSI) last announced its earnings results on Tuesday, March 3rd. The company reported ($0.08) earnings per share for the quarter, beating the consensus estimate of ($0.14) by $0.06. Quantum-Si had a negative return on equity of 43.90% and a negative net margin of 4,160.06%.The company had revenue of $0.45 million for the quarter, compared to the consensus estimate of $0.76 million. As a group, sell-side analysts expect that Quantum-Si Incorporated will post -0.65 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several brokerages have issued reports on QSI. Canaccord Genuity Group dropped their price objective on shares of Quantum-Si from $1.50 to $1.00 and set a “hold” rating on the stock in a research note on Wednesday, March 4th. Weiss Ratings restated a “sell (d-)” rating on shares of Quantum-Si in a research note on Monday, December 29th. Two analysts have rated the stock with a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, Quantum-Si currently has a consensus rating of “Hold” and a consensus target price of $3.25.

Institutional Inflows and Outflows

A number of hedge funds have recently added to or reduced their stakes in the stock. Prudential Financial Inc. acquired a new stake in shares of Quantum-Si in the 2nd quarter worth approximately $25,000. Curbstone Financial Management Corp acquired a new position in Quantum-Si during the fourth quarter worth $26,000. Capital Investment Advisory Services LLC boosted its position in Quantum-Si by 100.0% during the third quarter. Capital Investment Advisory Services LLC now owns 20,000 shares of the company’s stock worth $28,000 after purchasing an additional 10,000 shares in the last quarter. Leonteq Securities AG purchased a new stake in Quantum-Si during the fourth quarter worth $28,000. Finally, Elite Life Management LLC acquired a new stake in Quantum-Si in the third quarter valued at $29,000. 39.90% of the stock is owned by hedge funds and other institutional investors.

Quantum-Si Company Profile

Quantum-Si Inc is a life sciences instrumentation company headquartered in Guilford, Connecticut, developing next-generation proteomics solutions based on semiconductor sequencing technology. The company’s core offering centers on a proprietary single-molecule protein sequencing platform that uses a silicon-based sensor chip to convert protein data into digital signals. This approach is designed to deliver high sensitivity, single-amino-acid resolution and deep proteome coverage while potentially reducing cost and complexity compared to traditional mass spectrometry methods.

Quantum-Si’s product roadmap includes the development and commercialization of an integrated system comprising instruments, consumable reagents and proprietary data analysis software.